We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · November 16, 2021

All-Trans Retinoic Acid Plus Low-Dose Rituximab in ITP



Additional Info

All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP
Blood 2021 Oct 19;[EPub Ahead of Print], Y Wu, H Liu, QZ Zeng, Y Liu, JW Wang, WS Wang, J Feng, HB Zhou, QS Huang, Y He, HX Fu, XL Zhu, Q Jiang, H Jiang, YJ Chang, LP Xu, X Huang, XH Zhang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading